2019-10-11

LIPIGON ENTERS LICENSING AND COLLABORATION AGREEMENT WITH COMBIGENE TO DEVELOP GENE THERAPY FOR LIPODYSTROPHY

“We are very happy to enter this agreement with CombiGene ,” says Stefan K Nilsson, CEO at Lipigon

2018-05-28

CARINA SCHMIDT IS ANNOUNCED NEW CHAIRPERSON OF THE BOARD

Carina Schmidt has been appointed as the Chairperson of Lipigon Pharmaceuticals, she succeeds Gisela Sitbon.

2017-12-10

LIPIGON CEO AND CO-FOUNDER STEFAN K NILSSON HAS BEEN ELECTED COMMITTEE MEMBER OF PRESTIGOUS EUROPEAN LIPOPROTEIN CLUB

The European Lipoprotein Club (ELC) is the oldest and most active European meeting in the field of lipids.

2017-10-11

LIPIGON PHARMACEUTICALS ENTERS INTO TARGET VALIDATION RESEARCH AGREEMENT WITH GERMAN ANTISENSE COMPANY SECARNA PHARMACEUTICALS

Lipigon Pharmaceuticals (“Lipigon”) announced today that it has entered into a Target Validation Research Agreement with Munich-based antisense therapeutics company Secarna Pharmaceuticals (“Secarna”).

2017-09-25

LIPIGON HAS BEEN NOMINATED AS UNIVERSITY SPIN-OUT OF THE YEAR

Lipigon is nominated as this year’s spin-out company at UmeåGalan2017.

2017-04-05

LIPIGON PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF A NEW CHAIRMAN OF THE BOARD

Effective immediately Lipigon is announcing Dr. Gisela Sitbon as new Chairman of the Board.

2016-12-27

LIPIGON PHARMACEUTICALS JOINS ASTRAZENECA’S BIOVENTURHUB

Starting December 2016 Lipigon joins the AZ BioVentureHub located at AstraZeneca’s site in Mölndal, Sweden.

2016-12-20

LIPIGON WELCOMES NEW INVESTORS AND PARTNERS

Lipigon is happy to announce 3 new major partners investing in the company.

2016-06-30

LIPIGON CEO STEFAN K. NILSSON IN INTERVIEW AS INVITED SPEAKER FOR BIOFIT 2016

Lipigon CEO Stefan K. Nilsson is an invited speaker at BioFIT 2016 in Lille, France.

2016-03-30

MIKAEL ELOFSSON INTERVIEWED AT ADD 2016

Lipigon board member Prof. Mikael Elofsson interviewed at ADD 2016

2016-03-14

LIPIGON PHARMACEUTICALS AND ASTRAZENECA ENTER DRUG DISCOVERY COLLABORATION

​

Lipigon Pharmaceuticals today announced that it has entered into a research collaboration with AstraZeneca.

2016-03-02

AVAILABLE POSITIONS

Lipigon is expanding and looking for new talents to join our team.

2016-02-04

LIPIGON AWARDED CONNECT´S PITCH PRIZE

Lipigon awarded Connect´s pitch prize at Biotech Umeå investment Day

2015-12-10

LIPIGON PATENT APPLICATION PUBLISHED

Lipigon’s first patent application “New plasma lipid lowering agents”...

2015-09-02

LIPIGON SCIENTISTS PUBLISH IN PRESTIGIOUS JOURNAL

Lipigon scientists publish SAR relationship in Eur J Med Chem.

2015-05-02

LIPIGON CEO TO FRONT NATIONAL SSMF CAMPAIGN

CEO Stefan K Nilsson is one of out of five promising young scientists that has been selected to front the Swedish Society for Medical Research’s fund raising campaign.

2014-11-18

LIPIGON SIGNS DEAL WITH ASTRAZENECA

Lipigon Pharmaceuticals and AstraZeneca enter research collaboration to develop a high throughput assay for the identification of molecules that modulate lipoprotein lipase activity.

2014-09-05

LIPIGON CEO STEFAN K NILSSON RECEIVES SSMF POSTDOCTORAL AWARD

Lipigon CEO Dr. Stefan K Nilsson has been awarded the Swedish Society for Medical Research postdoctoral support.

2014-06-28

LIPIGON SCIENTISTS IDENTIFIES LPL ACTIVATORS

Lipigon scientists publish results for first LPL activators

2014-01-27

LIPIGON ATTENDS: BIOTECH UMEÅ INVESTMENT DAY

Lipigon attends: Biotech Umeå investment Day at Grand Hotel Stockholm.

2014-01-18

LIPIGON ATTENDS: SWISS-SWEDEN

Lipigon attends: Swiss-Sweden